Allergan Inc (AGN)
19 Dec 2014
|Market Cap (Mil.):||$63,342.19|
|Shares Outstanding (Mil.):||297.90|
BOSTON - Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm's biggest bet of 2014.
(Adds details from Ackman's letter about other investments)
BOSTON, Nov 26 - Hedge fund manager William Ackman told investors in a letter that his firm still owns 26.6 million shares in Allergan Inc. which were valued at $5.6 billion one week after the Botox maker agreed to sell itself to rival pharmaceutical company Actavis Plc.
- Generic drugmaker Actavis Plc is planning to cut employees and expand in China, a Bloomberg report said citing an interview by Chief Executive Officer Brent Saunders on Bloomberg Television.
(Corrects first bullet point to remove incorrect reference to Valeant's prior stake in Allergan)
- (Refiles Nov. 20 story to correct reference to previous stake)
Nov 20 - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.
NEW YORK - After months of fending off a hostile bid, Allergan Inc Chief Executive David Pyott made the right call in selling to rival Actavis Plc , whose stock price could nearly double in the next two years, a prominent investor said on Wednesday.
NEW YORK - Stock markets around the world rose on Tuesday and the yen hit a seven-year low as news of a snap election and a delayed tax increase in Japan bolstered hopes for new stimulus measures a day after data showed the country was back in recession.
|Astellas Pharma Inc (4503.T)||¥1,702||+47.50|
|Santen Pharmaceutical Co Ltd (4536.T)||¥6,510||+140.00|
|Lupin Limited (LUPN.NS)||Rs1,441.20||+23.15|
|Nestle SA (NESN.VX)||CHF72.25||+0.85|
|Johnson & Johnson (JNJ.N)||$106.57||+1.02|
|Pfizer Inc. (PFE.N)||$32.03||+0.09|
|Novartis AG (NOVN.VX)||CHF93.05||+0.95|
|High Tech Pharm Co.,Ltd. (106190.KQ)||₩13,700.00||--|
|Merck & Co., Inc. (MRK.N)||$58.75||-0.83|
|Roche Holding Ltd. (ROG.VX)||CHF270.40||-18.30|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Trading Report for (AGN). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALLERGAN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
"The Economy Matters" Report for AGN: the economy's impact on AGN's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider: MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.